100 results
Biotechnology companies have been increasing competition from generic drug makers as patents on several blockbuster drugs continue to expire. In 2013 alone, patents on drugs with annual sales of nearly $30 billion are set to expire. For biotechnology ...Stockhouse · 5/8/2013
In-depth coverageACAD), Cell Therapeutics Inc. (NASDAQ: CTIC), and Medivation Inc. (NASDAQ: MDVN). StockCall analysts initiated preliminary technical research on DNDN, SRPT, ACAD, CTIC, and MDVN. These free reports are accessible by signing today at4-traders · 5/8/2013
SEATTLE, May 15, 2013 /PRNewswire/ – Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that management will present at the following upcoming investor conferences. UBS Global Healthcare Conference Tuesday, May 21, 2013 at …Daily Markets · 5/14/2013
Cell Therapeutics (NASDAQ:CTIC) is one of today's best performing low-priced stocks, up 11.5% to $1.16 on 2.2x average daily volume. Cell Therapeutics has traded 2.7 million shares thus far today, vs. average volume of 1.2 million shares per day.Comtex Smartrend · ByJames Quinn · 3/28/2013
Pursuant to a request from CONSOB, the Italian securities regulatory authority, Cell Therapeutics, Inc. (the "Company") issued a press release in Italy on April 30, 2013 (the "Press Release"), providing certain requested financial information for the month ...Yahoo! Finance · 4/30/2013
Find out if (CTIC) is in Cramer's Portfolio. BOSTON (TheStreet) -- When i it comes to reverse stock splits, I'm willing to give biotech CEOs a single mulligan. We all know drug development is rooted in failure so even well-meaning biotech CEOs ...TheStreet.com · 4/18/2013
Total revenues for the first quarter of 2013 were $1.1 million. The revenues were solely attributable to net product sales of PIXUVRI. CTI sells PIXUVRI directly to health care providers and through a limited number of wholesale distributors in ...Reuters · 5/2/2013
Stock Gainers: Cell Therapeutics Inc, Fortress Investment Group LLC, Banro Corporation, Harmonic Inc
issues news alert on the following stocks:- Cell Therapeutics Inc (NASDAQ:CTIC) shares increased 7.41% to $1.16. The company, on Mar. 26, announced it has entered into a loan agreement with Hercules Technology Growth Capital, Inc. (NYSE: HTGC) …SBWire · 4/23/2013
Cell Therapeutics announces NICE issue draft guidance on PIXUVRI Co announces that the National Institute for Health and Care Excellence (NICE), a non-departmental public body of the Department of Health in the UK, issued draft guidance on ...MSN Money · 4/10/2013
HATTIESBURG, Miss.--(BUSINESS WIRE)-- The First Bancshares, Inc. (NASDAQ: FBMS), holding company for The First, A National Banking Association, (www.thefirstbank.com) will make a presentation to bank …I4U NEWS · 5/9/2013
POPULAR NOW
- © 2013 Microsoft |
- Privacy and Cookies |
- Legal |
- Advertise |
- About our ads |
- Help |
- Feedback